WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004002421) METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/002421    International Application No.:    PCT/US2003/020428
Publication Date: 08.01.2004 International Filing Date: 27.06.2003
IPC:
A61K 38/00 (2006.01), A61K 38/21 (2006.01), A61K 39/395 (2006.01), C07K 16/28 (2006.01)
Applicants: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804 (US) (For All Designated States Except US).
MARTIN, Roland [US/US]; (US) (For US Only).
MCFARLAND, Henry, F. [US/US]; (US) (For US Only).
BIELEKOVA, Bibiana [SK/US]; (US) (For US Only)
Inventors: MARTIN, Roland; (US).
MCFARLAND, Henry, F.; (US).
BIELEKOVA, Bibiana; (US)
Agent: SIEGEL, Susan Alpert; Klarquist Sparkman, LLP, One World Trade Center, Suite 1600, 121 SW Salmon Street, Portland, OR 97204 (US)
Priority Data:
60/393,021 28.06.2002 US
PCT/US02/38290 27.11.2002 US
Title (EN) METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
(FR) PROCEDE DE TRAITEMENT DE LA SCLEROSE EN PLAQUES
Abstract: front page image
(EN)A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of an IL-21 receptor antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby treating the subject.
(FR)L'invention concerne un procédé de traitement d'un sujet souffrant de sclérose en plaques. Dans un mode de réalisation, le procédé selon l'invention consiste à administrer au sujet une quantité thérapeutique efficace d'un antagoniste du récepteur d'IL-21 lorsque ce sujet n'a pas réagi au traitement avec l'interféron bêta, de manière à traiter ledit sujet.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)